戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              We previously demonstrated that 10 mM Mg(2+), 400 mM NaC
2                                              We previously demonstrated that 24-nt sRNAs are mobile f
3                                              We previously demonstrated that 48% of patients with pai
4                                              We previously demonstrated that a class II histone deace
5                                              We previously demonstrated that a conformationally sensi
6                                              We previously demonstrated that a high fat diet leads to
7 oximal external region (MPER)-specific BnAb, we previously demonstrated that a key obstacle to BnAb i
8                                              We previously demonstrated that a major pathologic respo
9                        In nonhuman primates, we previously demonstrated that a maternal high-fat diet
10 Gram-positive bacteria, including E. faecium We previously demonstrated that a nonpiliated DeltaempAB
11                                              We previously demonstrated that a P73G mutation blocks t
12                                              We previously demonstrated that a P73G mutation that lie
13 f monocyte/macrophage/DC lineages.IMPORTANCE We previously demonstrated that a pathogenic SIVmac239 v
14                                              We previously demonstrated that a recombinant A/sw/Texas
15                                              We previously demonstrated that a recombinant, soluble,
16 ecule, SA-4-1BBL, as the adjuvant of choice, we previously demonstrated that a single vaccination wit
17                                              We previously demonstrated that a tumor lysate vaccine/F
18                                              We previously demonstrated that acquired increased TRPC6
19                                              We previously demonstrated that actin depolymerization u
20                                              We previously demonstrated that activated B-Raf/MEK/ERK
21                                              We previously demonstrated that active Smoothened mutant
22                                              We previously demonstrated that adding a third DAA to le
23                                              We previously demonstrated that adenosine A2A receptor (
24                                              We previously demonstrated that adipocyte-MR overexpress
25                                              We previously demonstrated that administration of Akkerm
26                                              We previously demonstrated that AI in mice carrying the
27                                              We previously demonstrated that Ang II, via its type 1 r
28                                              We previously demonstrated that angiogenin administratio
29                                              We previously demonstrated that Arg-Gly-Asp (RGD)-contai
30                                              We previously demonstrated that ASS1 silencing is contro
31                                              We previously demonstrated that astrocyte-secreted facto
32                                              We previously demonstrated that at the mitochondria, mut
33                                              We previously demonstrated that ATF2 is a nucleocytoplas
34                                              We previously demonstrated that ATP-independent metallop
35                                              We previously demonstrated that bacterial flagellar moti
36                        In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl-1 coopera
37                                              We previously demonstrated that beta cells express neuro
38                                              We previously demonstrated that binding of Grg4 to an Eh
39                                              We previously demonstrated that biological transcription
40                                              We previously demonstrated that bone marrow-derived MSCs
41                                              We previously demonstrated that both human and mouse ath
42 h capacity compacted DNA nanoparticles (NP), we previously demonstrated that both plasmid and NP form
43                                              We previously demonstrated that carbon dioxide inhalatio
44                                              We previously demonstrated that cardiac myosin can use 2
45                                              We previously demonstrated that CCN2 triggers signaling
46                                              We previously demonstrated that CD1d-restricted type II
47                                              We previously demonstrated that CD8(+) T cell responses
48 l tools to differentiate membrane responses, we previously demonstrated that cell surface mGluR5 trig
49                                              We previously demonstrated that chronic hyperglycemia ha
50                                              We previously demonstrated that cNK-lysin and cNK-2, a s
51                                              We previously demonstrated that co-occurring, weight-dep
52                                              We previously demonstrated that coagulation factor VIII
53                                              We previously demonstrated that coinfection with P. mira
54                                              We previously demonstrated that complement C3b binding a
55                                              We previously demonstrated that computed tomography (CT)
56                                              We previously demonstrated that conditional expression o
57                                              We previously demonstrated that consumption of a Western
58                                              We previously demonstrated that contextual fear conditio
59                                              We previously demonstrated that CRF receptor 1 (CRF1) ne
60                                              We previously demonstrated that crosslinking of HLA I by
61                                              We previously demonstrated that CS-generated ROS, partic
62                                              We previously demonstrated that cutaneous epithelium exh
63                                              We previously demonstrated that cyclosporine A treatment
64                                              We previously demonstrated that daily practice of a sust
65                                              We previously demonstrated that DcR3 modulates macrophag
66                                              We previously demonstrated that dendritic cells (DCs) ex
67                                              We previously demonstrated that dendrons bearing multipl
68                                              We previously demonstrated that dexamethasone (Dex) inhi
69                                              We previously demonstrated that ectodomain residue Asp28
70                                              We previously demonstrated that ectopic overexpression o
71                                              We previously demonstrated that EHEC senses acyl-homoser
72                                              We previously demonstrated that endoglin, a type III tra
73                                              We previously demonstrated that endothelial NO acts as a
74                                              We previously demonstrated that Entamoeba histolytica se
75                                              We previously demonstrated that entinostat enhanced NKG2
76                                              We previously demonstrated that ERFE messenger RNA expre
77 ing ERK activation are not fully understood, we previously demonstrated that ERK phosphorylation is e
78                                              We previously demonstrated that erythropoietin-stimulate
79                                              We previously demonstrated that ESyt2 interacts specific
80                                              We previously demonstrated that exposure to DEP was asso
81                                              We previously demonstrated that expression of CHMP2B(Int
82                                              We previously demonstrated that female mice lacking GLUT
83                                              We previously demonstrated that fibroblasts stimulated w
84 the HIV Tat-mediated positive-feedback loop, we previously demonstrated that fluctuations in viral Ta
85                                              We previously demonstrated that fungal pathogens can pro
86                                              We previously demonstrated that galectin (Gal)-8, from t
87                                              We previously demonstrated that ganglioside GD3 is a maj
88                                              We previously demonstrated that gB homologs from two alp
89                                              We previously demonstrated that genetic and/or pharmacol
90 inuous Glucose Monitoring (CGM) murine model we previously demonstrated that genetic deficiencies of
91                                              We previously demonstrated that gentamicin produced func
92                                              We previously demonstrated that global and prefrontal co
93                                              We previously demonstrated that global deletion of mitoc
94                                              We previously demonstrated that global inhibition of miR
95                                              We previously demonstrated that glucose deprivation stim
96                                              We previously demonstrated that GroEL-GroES enhances the
97                                              We previously demonstrated that gut Camp expression is u
98                                              We previously demonstrated that haploinsufficiency of Eg
99                                              We previously demonstrated that HCMV infection maintains
100                                              We previously demonstrated that hernia formation is asso
101                                              We previously demonstrated that heterogeneous genomics d
102                                              We previously demonstrated that HIC1 can be either acety
103                                              We previously demonstrated that high reactive oxygen spe
104                                              We previously demonstrated that HIV replication is conce
105                                              We previously demonstrated that HIV-1 restriction by MxB
106                                              We previously demonstrated that host protective expulsio
107                                              We previously demonstrated that hTRF2 is a double strand
108                                              We previously demonstrated that hypercapnia suppresses i
109                                              We previously demonstrated that ICG-001, a small molecul
110                                              We previously demonstrated that IFN-alphabetagammaR(-/-)
111                                              We previously demonstrated that IgG-IC directly excited
112                                              We previously demonstrated that IkappaBalpha markedly in
113                                              We previously demonstrated that IL1R2 intracellularly ac
114                                              We previously demonstrated that immunization of lactatin
115                                              We previously demonstrated that in neutrophils, mammalia
116                                              We previously demonstrated that individual patients with
117                       In a clinical setting, we previously demonstrated that induction therapy by lym
118                                              We previously demonstrated that insertion of a foreign g
119                                              We previously demonstrated that insulin-mediated severe
120                                              We previously demonstrated that intact heat-killed Strep
121                                              We previously demonstrated that intact, inactivated Stre
122                                              We previously demonstrated that interleukin-1alpha (IL-1
123                                              We previously demonstrated that intermittent access to p
124                                              We previously demonstrated that intracellular NADPH oxid
125                                     However, we previously demonstrated that intracellular replicatio
126                                              We previously demonstrated that intracytoplasmic sperm i
127                                              We previously demonstrated that isoflurane targets lymph
128 understood as a Galphaq/11-coupled receptor, we previously demonstrated that it could couple to and s
129                                              We previously demonstrated that it is possible to genera
130                                              We previously demonstrated that knockdown of Max express
131                                              We previously demonstrated that leucine-rich repeat and
132                                              We previously demonstrated that LIS1 involvement in the
133 ing conditional knockout strategies of CD28, we previously demonstrated that loss of CD28 signaling i
134                                              We previously demonstrated that loss of the retinoblasto
135                                              We previously demonstrated that Lou/C animals express UC
136                                              We previously demonstrated that LPS binds to monocytic m
137                                              We previously demonstrated that lymphocyte function-asso
138                                              We previously demonstrated that lymphostatin is a putati
139                                              We previously demonstrated that MBP activates IgE-desens
140                                              We previously demonstrated that MCP-1 is important for E
141                                              We previously demonstrated that mesenchymal stem cells (
142                                              We previously demonstrated that MHV68 LANA (mLANA) is re
143                                              We previously demonstrated that mice harboring a kinase-
144                                              We previously demonstrated that micro-RNAs (miRNAs) 132
145                                              We previously demonstrated that microtubule defects infl
146                                              We previously demonstrated that mouse TH2 cells selectiv
147                                              We previously demonstrated that MPN cells become persist
148                                              We previously demonstrated that mutant mice with selecti
149                                              We previously demonstrated that mutations in keratin 10
150                                              We previously demonstrated that mutations predicted to w
151                                              We previously demonstrated that myeloid lineage-specific
152                                              We previously demonstrated that myomaker, a skeletal mus
153                                              We previously demonstrated that Neisseria gonorrhoeae, a
154                                              We previously demonstrated that neonates of asthmatic mo
155                                              We previously demonstrated that nerve cell lines selecte
156                                              We previously demonstrated that network level functional
157                                              We previously demonstrated that neutrophil extracellular
158                                              We previously demonstrated that NFAT1 contributes to mel
159                                              We previously demonstrated that NK cells from HIV-infect
160                                              We previously demonstrated that non-erythroid alpha-spec
161                                              We previously demonstrated that one or more products of
162                                              We previously demonstrated that over-expression of EC4-F
163                                              We previously demonstrated that overexpression of sarcos
164                                              We previously demonstrated that (p)ppGpp was required fo
165                                              We previously demonstrated that p28 can form an alternat
166                                              We previously demonstrated that p90 ribosomal S6 kinase
167                                              We previously demonstrated that palmitoylation of the AM
168                                              We previously demonstrated that pancreatic intraepitheli
169                                              We previously demonstrated that pancreatic stellate cell
170                                              We previously demonstrated that parasympathetic dysfunct
171                                              We previously demonstrated that parkin ubiquitinates TDP
172                                              We previously demonstrated that pathogenic SIVmac239 and
173                                              We previously demonstrated that pathogenic subretinal mo
174                                              We previously demonstrated that PEAK1-related kinase act
175                                              We previously demonstrated that PERV in vitro cell tropi
176                                              We previously demonstrated that PGE(2) synthesis by F. t
177                                              We previously demonstrated that pharmacological inductio
178                                              We previously demonstrated that phosphorylation of STIM1
179                                              We previously demonstrated that Plk4 accumulation is aut
180                                              We previously demonstrated that PrEP use does not enhanc
181                                              We previously demonstrated that presenilin and nicastrin
182                                              We previously demonstrated that prevention of hyperglyce
183                                              We previously demonstrated that proline content determin
184                                              We previously demonstrated that promoter-bound factors b
185                                              We previously demonstrated that protein-specific transfe
186                                              We previously demonstrated that Q9:VP2.139-specific CD8
187                                              We previously demonstrated that quinine-stimulated oromo
188                                              We previously demonstrated that RARalpha2 expression is
189                                              We previously demonstrated that rat CeA GABAergic transm
190                                              We previously demonstrated that reduction of spastin lea
191                                              We previously demonstrated that remodeling requires the
192                                              We previously demonstrated that retinoic acid (RAR-RXR)
193                                              We previously demonstrated that Rho kinase 2b (Rock2b) i
194                                              We previously demonstrated that RICD is impaired in T ce
195                                              We previously demonstrated that S. aureus MW2 (USA400) b
196                                              We previously demonstrated that SCD1 is important in lun
197                                              We previously demonstrated that selective inhibition of
198                                              We previously demonstrated that ShcA is necessary for th
199                                              We previously demonstrated that shear force can activate
200                                              We previously demonstrated that SHP represses the transa
201                                              We previously demonstrated that simian virus 40 (SV40) l
202                                              We previously demonstrated that SIRT6, a member of the m
203                                              We previously demonstrated that SLC30A10 is a cell surfa
204                                              We previously demonstrated that sodium butyrate is neuro
205                                              We previously demonstrated that sphingosine kinase 1 (Sp
206                                              We previously demonstrated that sphingosine, a sphingoli
207             In a rat ALS model (SOD1(G93A) ) we previously demonstrated that spinal respiratory motor
208                                              We previously demonstrated that sporadic canine colorect
209                                              We previously demonstrated that sterile protection induc
210                                              We previously demonstrated that substitution of Asp-362
211                                              We previously demonstrated that targeted loss of all sel
212                                              We previously demonstrated that TGF-beta1 suppresses IgE
213                                              We previously demonstrated that the 5' leader mRNA of th
214                                              We previously demonstrated that the A673T substitution m
215                                              We previously demonstrated that the adaptor molecule bre
216                                              We previously demonstrated that the Alzheimer's disease
217                                              We previously demonstrated that the ARC1 E3 ligase is re
218                                              We previously demonstrated that the autoantibodies elici
219                                              We previously demonstrated that the Bcl-2 homology 4 (BH
220                                              We previously demonstrated that the cAMP response elemen
221                                              We previously demonstrated that the CD133(-)/EpCAM(-) he
222 respiratory syncytial virus (RSV) infection, we previously demonstrated that the CD8(+) T cell immuno
223                                              We previously demonstrated that the combination of synth
224                                              We previously demonstrated that the cytosolic Hsc70-SGTA
225                                              We previously demonstrated that the deubiquitinating enz
226                                              We previously demonstrated that the dystrophin homologue
227                                              We previously demonstrated that the E2 proteins of diver
228 8)-linked polyubiquitin degradation signals, we previously demonstrated that the E6AP/UBE3A ligase ha
229                                              We previously demonstrated that the efficiency of fluore
230                                              We previously demonstrated that the enhancer of rudiment
231                                              We previously demonstrated that the epidermal growth fac
232                                              We previously demonstrated that the expression of both u
233                                              We previously demonstrated that the expression of positi
234                                              We previously demonstrated that the first intron of the
235                                              We previously demonstrated that the gene encoding h2-cal
236                                              We previously demonstrated that the GSK inhibitor lithiu
237                                              We previously demonstrated that the H. pylori cag(+) str
238                                              We previously demonstrated that the H. pylori cag(+) str
239                                              We previously demonstrated that the histone deacetylase
240                                              We previously demonstrated that the histone deacetylase-
241                                              We previously demonstrated that the histone demethylase
242                                              We previously demonstrated that the human Dna2 orthologu
243                                              We previously demonstrated that the human homolog, Las1L
244                                              We previously demonstrated that the induction of hematop
245                                              We previously demonstrated that the injection of brain e
246                                              We previously demonstrated that the kinesin-3 motor KIF1
247 oforms of Ras (Kirsten, Harvey, and Neural), we previously demonstrated that the Kirsten isoform is k
248                                              We previously demonstrated that the lipid environment is
249                                              We previously demonstrated that the marine sponge Hymeni
250                                              We previously demonstrated that the minor capsid protein
251                                              We previously demonstrated that the mitogen-activated pr
252                                              We previously demonstrated that the mTORC1/S6K1 pathway
253                                              We previously demonstrated that the Mycobacterium tuberc
254                                              We previously demonstrated that the neuronal guidance cu
255        Using a rat slot machine task (rSMT), we previously demonstrated that the nonspecific D(2) ago
256                                              We previously demonstrated that the NTHI Sap transporter
257                                              We previously demonstrated that the ORF9 gene is essenti
258                                              We previously demonstrated that the parasite expresses a
259                  Using an in vitro approach, we previously demonstrated that the pattern recognition
260                                              We previously demonstrated that the positively charged r
261 any RNA-binding proteins are methylated, and we previously demonstrated that the potent SG-nucleating
262                                              We previously demonstrated that the presence of HIV-spec
263                                              We previously demonstrated that the quantitative binding
264                                              We previously demonstrated that the r(GGGGCC)n RNA forms
265                                              We previously demonstrated that the small (+/- 10 kDa) v
266                                              We previously demonstrated that the small GTPase Rab17 r
267                                              We previously demonstrated that the small interfering RN
268                                              We previously demonstrated that the sphingolipid metabol
269                                              We previously demonstrated that the stimulation of CD1b-
270                                              We previously demonstrated that the synthetic analog of
271                                              We previously demonstrated that the TM sequences of five
272                                              We previously demonstrated that the transcription factor
273                                              We previously demonstrated that the transcription factor
274                                              We previously demonstrated that the type three secretion
275                                              We previously demonstrated that the ubiquitin-proteasome
276                                              We previously demonstrated that the UROS(C73R) mutant pr
277                                              We previously demonstrated that the yeast Hrq1 helicase
278                                        Since we previously demonstrated that these KO mice exhibit a
279                                              We previously demonstrated that this conjugation leads t
280                                              We previously demonstrated that this regimen could provi
281                                              We previously demonstrated that this targeting informati
282                                              We previously demonstrated that TICs have the capacity t
283                                              We previously demonstrated that tobacco plants grow phot
284                                              We previously demonstrated that tolerance induction by a
285                                              We previously demonstrated that Tpl2 regulates T cell re
286                                              We previously demonstrated that transient overexpression
287                                              We previously demonstrated that Tregs can be selectively
288                                              We previously demonstrated that trogocytosis also occurs
289                                              We previously demonstrated that TSHR, the target of this
290                                              We previously demonstrated that two pollen-expressed sPP
291                                              We previously demonstrated that UL99 interacts with the
292                                              We previously demonstrated that upregulation of trkB.T1,
293                                              We previously demonstrated that vaccination of lactating
294                                              We previously demonstrated that VCP/Cdc48-associated mit
295                                              We previously demonstrated that virus release is depende
296                                              We previously demonstrated that WDR5 binds the conserved
297                                              We previously demonstrated that Wnt16 regulates the somi
298                                              We previously demonstrated that WNV infection of mice de
299                                              We previously demonstrated that yeast cells exposed to a
300 by which YopM promotes virulence is unknown, we previously demonstrated that YopM was required for th

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top